U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06393972) titled 'The Efficacy and Safety of Tofacitinib in Patients With Glucocorticoid Resistant ICIs-related Myocarditis' on Nov. 23, 2023.
Brief Summary: The efficacy and safety of Tofacitinib in patients with glucocorticoid resistant ICIs-related myocarditis: a single-arm, prospective, phase 2 trial
Study Type: Interventional
Condition: Glucocorticoid Resistant ICIs-related Myocarditis
Intervention: Drug: Tofacitinib 5 MG BID
Tofacitinib 5 MG BID
Recruitment Status: Not Yet Recruiting
Published by HT Digital Content Services with permission from Health Daily Digest....